Myanmar’s first antibiotic producing plant, a joint venture between Australia based drug maker Zifam and Pyrex Trading Co.,Ltd. Myanmar, was opened in the Thilawa Special Economic Zone to meet the domestic drug demand

To meet the domestic drug demand, an antibiotic producing plant was opened in the Thilawa Special Economic Zone on May 12.

Australia based drug maker Zifam will produce three categories of drugs under the name of Zifam Pyrex Myanmar Co., Ltd in collaboration with local company named Pyrex Trading Co., Ltd.

“We are glad to announce antibiotics locally. Sometimes, drug shortages occur because imported drugs haven’t arrived on time. Having a local plant will reduce money flowing outside of the country, and illicit drugs and fake drugs from flowing in,” Dr. Khin Thiri, Member of Director from Zifam Pyrex Myanmar Co., Ltd, said.

The company grantees to offer high quality drugs with lower prices compared to imported drugs.

“The facility will create jobs and give technical know-how to local workers,” Dr. Myint Htwe, Union Minster of the Ministry of Health and Sport, said.

Producing high quality drugs locally can help reduce the illicit drug trade and fake drugs from following into the country via border gates.

Firstly, the plant will produce Flumox which can be used both as an injection or oral dose.

Currently, Myanmar is importing Flumox from India, but Zifam expects to produce it to meet the demand and further for exports.

(Myanmar Business Today: https://www.mmbiztoday.com/articles/myanmar-s-first-antibiotic-plant-now-operational )

​